H
IV-infected subjects are at a higher risk of developing cardiovascular disease (CVD) because of both the infection and its treatment with protease inhibitor drugs [1] [2] [3] [4] . Higher carotid intimal-medial thickness is associated with CVD risk factors and has been accepted as a validated marker for the process of atherosclerosis [5, 6] . Endothelial dysfunction is one of the initial pathologic processes of atherosclerosis. The sonographic assessment of brachial flowmediated dilation is a validated research technique to quantify endothelial function. Impaired flow-mediated dilatation may precede atherosclerosis. However, the measurements rely on biologic and technical variabilities that are difficult to control. Moreover, sonographic assessment of brachial artery reactivity is technically chal-OBJECTIVE. The purpose of this article is to assess the differences, if any, in the values of carotid artery stiffness parameters between HIV-infected subjects without known cardiovascular disease (CVD) or carotid artery plaques and HIV-uninfected control subjects matched for sex, age, body mass index, and other CVD risk factors (i.e., hypertension, hypercholesterolemia, diabetes, and cigarette smoking). Arterial stiffness is emerging as predictor of CVD risk. By recording the blood pressure, an automated echo-tracking system implemented in ultrasound equipment allows evaluation of arterial stiffness.
SUBJECTS AND METHODS. Fifty-four HIV-infected patients without a history of CVD were closely matched for sex, age, body mass index, and CVD risk factors to 54 HIVuninfected control subjects on an individual basis. Ultrasound studies of carotid artery stiffness parameters were performed using ultrasound equipment with a linear broadband highfrequency transducer. Carotid intima-media thickness was also measured. Repeatability between operators was assessed. Nonparametric Mann-Whitney U test, chi-square statistics, Fisher exact test, Pearson correlation coefficient, and intraclass correlation coefficient were used for statistical analysis. A p value less than 0.05 was considered statistically significant.
RESULTS. Except for arterial compliance in HIV-infected subjects, arterial stiffness parameters were correlated with age in both groups. Compared with matched control subjects, HIV-infected subjects showed lower arterial compliance parameter values (0.95 [interquartile range, 0.78-1.23] vs 0.76 [interquartile range, 0.62-1.00]; p = 0.0009), whereas other parameters were similar. Repeatability between operators was good.
CONCLUSION. HIV-infected subjects have an arterial compliance significantly lower than that of control subjects. The impairment of carotid artery distensibility may contribute to subclinical atherosclerosis.
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carotid artery plaques and HIV-uninfected control subjects matched for sex, age, body mass index, and other CVD risk factors (i.e., hypertension, hypercholesterolemia, diabetes, and cigarette smoking). The subjects enrolled into the study were examined at each center after remaining in a supine position for at least 10 minutes in a quiet temperature-controlled room. Systolic and diastolic blood pressures were measured from the left brachial artery with a sphygmomanometer immediately before acquisition of carotid artery images on the right and left side, and the data were entered into the computer system of the ultrasound machine to allow automatic computation of mechanical properties parameters of the carotid arteries. Patients' medications were not withheld or altered during the study.
Subjects and Methods
Study Design
In all participating centers, ultrasound studies were performed by physicians with more than 5 years of experience in performing carotid imaging, using ultrasound equipment with specialized wall-tracking software (ProSound α 10, Aloka) and equipped with a linear broadband highfrequency transducer. The echo-tracking software allows accurate measurements of the maximum and minimum diameter of arteries in systole and diastole through ultrasound examination. It uses radiofrequency signals to measure vessel diameter in real time, achieving an accuracy of 0.01 mm at an ultrasound probe frequency of 10 MHz, thus allowing the detection of small phase shifts of the radiofrequency echo signal caused by the displacement of the vessel wall. Measurements were performed as described elsewhere [11] . Briefly, the tracking gate was set on the B-mode image on the boundary between media and adventitia to automatically track the movement of the vessel wall. All acquisitions were synchronized with the ECG signal monitored continuously from three chest electrodes. Systolic-diastolic changes in vessel diameter were displayed on the monitor as waveforms (Fig. 1) . At least five waveforms were manually selected and then automatically averaged by the system to calculate the parameters of the mechanical properties of the carotid arteries (i.e., vascular stiffness parameters). These parameters were the β-index, pressure-strain elastic modulus, arterial compliance, augmentation index, and 1-point pulse wave velocity. Higher β-index, pressure-strain elastic modulus, augmentation index, and 1-point pulse wave velocity values indicate stiffer vessels, whereas lower arterial compliance values indicate less extensible vessels. The formulas used to calculate each parameter are reported in Table 1 .
Three consecutive measurements were performed for each parameter and then averaged for statistical analysis. The left and right common carotid arteries were examined separately.
Carotid intima-media thickness was measured on the far wall of both the left and right common carotid arteries imaged on longitudinal scan. Measurements were taken approximately 10 mm proximal to the bifurcation, and end-diastolic images were used. Intima-media thickness was defined as the distance between the first and second echogenic lines from the lumen, taking the average 
TABLE 1: Formulas Used to Calculate Echo-Tracked Parameters of Mechanical Properties of Common Carotid Artery
Parameter Formula
One-point pulse wave velocity (m/s) Square root of (β × DBP / 2ρ) Augmentation index (%) (P 2 − P 1 ) / (SBP − DBP) × 100
Note-ρ = blood density (1050 kg/m 3 ), DBP = diastolic blood pressure, Dd = diastolic vessel diameter, Ds = systolic vessel diameter, ln = natural logarithm, P 1 = first systolic peak of the central pressure waveform, P 2 = second systolic peak of the central pressure waveform, SBP = systolic blood pressure. 
Multicenter Study of Arterial Stiffness in HIV-Positive Patients
Study Subjects
Fifty-four HIV-infected patients without a history of CVD who agreed to participate were enrolled into the study and were closely matched for sex, age, body mass index, and CVD risk factors to 54 HIV-uninfected control subjects on an individual basis-that is, each case patient was paired with a control subject. In addition, antiretroviral treatment and virus load at the time of measurements of arterial stiffness parameters were recorded. Patients' demographics and CVD risk factors were determined by interview and chart review. Individual 10-year CVD risk score was determined by age, sex, systolic blood pressure, high-density lipoprotein cholesterol, total cholesterol, cigarette smoking, diabetes, and hypertension treatment (if present), according to a formula based on the Framingham algorithm.
The study complies with the Declaration of Helsinki, and the ethics committee at each participating center approved the study protocol. Written informed consent was obtained from all participants.
Statistical Analysis
Medians and interquartile ranges (IQRs) were used to summarize quantitative variables because they are not normally distributed (Shapiro test); 95% CIs are also shown. Counts and percentages were used for qualitative variables. The nonparametric Mann-Whitney U test was used to compare quantitative variables between groups. The chi-square statistic or Fisher exact test, as appropriate, was applied to compare qualitative variables. The Pearson correlation coefficient (r) was used to evaluate the correlation between parameters. Repeatability between operators was assessed with the intraclass correlation coefficient. A p value less than 0.05 was considered statistically significant. All tests were two sided. Data analysis was performed with the STATA statistical package (release 10.0, StataCorp).
Results
Demographic characteristics, CVD risk factors, and antiretroviral treatment for the HIV-infected subjects are reported in Table 2. All but two patients (52/54 [96.3%]) received highly active antiretroviral therapy (HAART), consisting of protease inhibitors, nonnucleoside reverse-transcriptase inhibitors, or nucleoside analogs, in different combinations. Twenty-seven of 54 patients (50.0%) received combination therapy with a protease inhibitor. Nine of 54 patients (16.7%) had a detectable virus load. Eleven of 54 patients (20.4%) were coinfected with hepatitis C virus (HCV).
Except for arterial compliance in HIV-infected subjects, arterial stiffness parameters correlated with age in both groups (Table 3) . Descriptive statistics of vascular stiffness parameters in HIV-infected patients and control-matched subjects are reported in Table  4 The intraclass correlation coefficients (ρ) between measurements performed by the two operators were 0.94 (95% CI, 0.87-1.00) for β-index calculation, 0.83 (95% CI, 0.66-1.00) for pressure-strain elastic modulus calculation, 0.97 (95% CI, 0.93-1.00) for arterial compliance calculation, 0.95 (95% CI, 0.89-1.00) for augmentation index calculation, 0.86 (95% CI, 0.72-1.00) for 1-point 10-year cardiovascular disease risk score (%) 2 (0.7-3.0) 2 (0.9-3.1)
Note-Except where noted otherwise, data are median (interquartile range).
Ferraioli et al. pulse wave velocity calculation, and 0.81 (95% CI, 0.60-1.00) for carotid intimal-medial thickness calculation.
Discussion
In this study, several carotid artery stiffness parameters of HIV-infected subjects were compared with those of closely matched uninfected control subjects. The results show that HIV-infected subjects have an arterial compliance, which is the quantitative measure of the distensibility of the arterial system, that is significantly decreased compared with that of control subjects, whereas other indexes of local vascular stiffness were similar. The advent of HAART has dramatically decreased the mortality related to HIV infection. On the other hand, chronic diseases, including atherosclerosis, represent an increasing health issue in this patient population [3] . HIV-infected subjects have a heightened inflammatory status, with enhanced endothelial activation despite virologic suppression [12] . In HIV infection, the mechanisms that account for the increased risk of developing atherosclerosis are not well established and may be related to viral infection itself, the use of HAART, or altered immune response [3, 4] . The findings of this study suggest that, in HIV-infected subjects, there is an impairment of carotid artery distensibility that may contribute to subclinical atherosclerosis. The reduction in arterial compliance values was independent of antiretroviral treatments at the time of the measurements. It has been argued that even effective HAART may not repair the damage done by the HIV infection [13] . The impairment of arterial compliance could be related to the increased vascular inflammation reported by others [4, 12, 14] .
In the present study, no differences were observed for carotid intimal-medial thickness between HIV-infected patients and control subjects. This result is in agreement with other studies that found little association between HIV infection and intima-media thickness measured in the common carotid artery [15] [16] [17] [18] . In the FRAM study [15] , a stronger association between HIV infection and intima-media thickness in the internal and bulb region, compared with the common carotid artery, was found. On the other hand, it should be pointed out that our HIV-infected patient population was a selected one, because patients with overt atherosclerotic diseases or carotid plaques at ultrasound examination were excluded. Moreover, only patients who voluntarily accepted to participate in the study were examined; thus, a bias resulting from a higher compliance with treatment in our patient population could have affected the results of this study. It could be speculated that these patients were also better motivated to comply with treatment. In the SMART study, patients assigned to receiving continuous HAART had a decreased risk of fatal and nonfatal CVD compared with patients receiving intermittent HAART [10] .
Except for arterial compliance in HIV-infected subjects, arterial stiffness parameter values correlated with age in both groups. This finding is in agreement with data in the literature [19, 20] . The lack of correlation with age for arterial compliance values in HIV-infected subjects could be due to the already significant impairment of arterial distensibility.
Among the limitations of this study is the lack of assessment of inflammatory biomarkers that are linked to CVD events, such as Creactive protein, interleukin-6, and d-dimer [21] . Their measurements would have been valuable in correlating the compliance measurements with the degree of endothelial inflammation. On the other hand, the aim of this study was only to assess differences in the values of arterial stiffness parameters, determined by echo-tracking technique, between HIV-infected and control-matched subjects.
Another limitation of this study is that blood pressure was measured at the brachial artery, whereas stiffness measurements were performed at the carotid artery. This could lead to a somewhat inaccurate estimation of the arterial stiffness parameters. Nonetheless, this inaccuracy disappears when we compared two series of subjects in whom measurements were performed in a similar way.
The ultrasound imaging technique relies on the ability to image the walls of the vessels being studied accurately, and some concerns have been raised about the reproducibility of the technique [22] . Nowadays, the availability of echo-tracking systems that evaluate raw radiofrequency signals allows the detection of very small changes in vessel diameter. In this study, good repeatability between measurements performed by experienced operators was observed.
To the best of our knowledge, this is the first study conducted to compare local arterial stiffness parameters of HIV-positive subjects with that of closely matched uninfected control subjects using a noninvasive readily available imaging technique. Further studies are needed to investigate the relationship of these parameters with virus loads and different HAART regimens.
